ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1430

The Role of Lung Biopsy in Pediatric ANCA-associated Vasculitis

Edouard Sayad1, Tiphanie Vogel1, David Moreno McNeill1, Nahir Cortes-Santiago1, David Spielberg1, Kalyani Patel1 and Manuel Silva Carmona1, 1Baylor College of Medicine/Texas Children's Hospital, Houston, TX

Meeting: ACR Convergence 2020

Keywords: ANCA, ANCA associated vasculitis, Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis, pulmonary

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Vasculitis – ANCA-Associated Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Anca-associated vasculitis (AAV) is characterized by vascular inflammation in multiple organs. The diagnosis can be made clinically using a number of different criteria. The lungs are commonly affected, with a broad range of manifestations described including cough, dyspnea, respiratory failure, and pulmonary hemorrhage. Multiple pulmonary histopathologic patterns have been described in AAV, which requires invasive tissue sampling through lung biopsy and is not without risk. Here, we have reviewed the histopathologic findings in a series of pediatric AAV, and discuss procedural outcomes and yield of lung biopsies in this population.

Methods: After IRB approval, we performed a retrospective chart review of all patients < 18 years of age presenting to our institution with a diagnosis of AAV who underwent lung biopsy. We reviewed histopathologic features, serologies, timing of biopsy, and complications.

Results: 14 patients met inclusion criteria, 9 patients with a diagnosis of microscopic polyangiitis (MPA), and 5 patients with granulomatosis with polyangiitis (GPA). 10/14 (71%) of the biopsies were performed between 2009 and 2013, and only 4 (29%) from 2015 to present. 13/14 patients required initial admission on presentation for respiratory symptoms. 11/14 required respiratory support. All patients had abnormal chest imaging at presentation. 11/14 had concerns for pulmonary hemorrhage. All 5 patients with GPA had an elevated serine protease-3 (PR3). Mean PR3 level was 703 AU/mL (range 49-1353 AU/mL). Myeloperoxidase (MPO) was elevated in all MPA patients. Mean MPO level was 109 AU/mL (range 24-186 AU/mL). The indication for biopsy was to confirm the diagnosis prior to initiating therapy in 11 patients (78%), as part of an infectious work-up in 2 (14%), and as part of an interstitial lung disease work-up in 1 (7%).  9/14 (64%) biopsies had findings consistent with a diagnosis of AAV, 4/9 (44%) of the MPA patients compared to 5/5 (100%) of the GPA patients. The most common findings on histopathology in GPA patients were vasculitis (100%), granulomatous changes (20%), and alveolar hemorrhage (60%). Only 44% of MPA patients had signs of vasculitis, but 100% showed signs of alveolar hemorrhage. The main post-procedure complication was pneumothorax, in 28% of patients.

Conclusion: We found that lung biopsy had a higher diagnostic yield in GPA compared to MPA. On histology, confirmation of vasculitis and pulmonary hemorrhage were the most common findings. In our cohort, the diagnosis of AAV was able to be made with clinical features and a positive serology in all cases. Therefore, considering the risks associated with obtaining a lung biopsy, they should not be routine and reserved for uncertain cases.


Disclosure: E. Sayad, None; T. Vogel, None; D. Moreno McNeill, None; N. Cortes-Santiago, None; D. Spielberg, Vertex Pharmaceuticals, 2; K. Patel, None; M. Silva Carmona, None.

To cite this abstract in AMA style:

Sayad E, Vogel T, Moreno McNeill D, Cortes-Santiago N, Spielberg D, Patel K, Silva Carmona M. The Role of Lung Biopsy in Pediatric ANCA-associated Vasculitis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/the-role-of-lung-biopsy-in-pediatric-anca-associated-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-role-of-lung-biopsy-in-pediatric-anca-associated-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology